v3.25.1
Condensed Consolidated Statements of Stockholders’ Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2023   253,958,000      
Beginning balance at Dec. 31, 2023 $ 654,952 $ 25 $ 1,657,133 $ (94) $ (1,002,112)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of stock options (in shares)   869,000      
Issuance of common stock upon exercise of stock options 103   103    
Issuance of common stock in connection with restricted stock units, net of tax (in shares)   100,000      
Issuance of common stock in connection with restricted stock units, net of tax (76)   (76)    
Stock-based compensation 9,155   9,155    
Other comprehensive loss (310)     (310)  
Net loss (60,667)       (60,667)
Ending balance (in shares) at Mar. 31, 2024   254,927,000      
Ending balance at Mar. 31, 2024 $ 603,157 $ 25 1,666,315 (404) (1,062,779)
Beginning balance (in shares) at Dec. 31, 2024 294,875,546 294,876,000      
Beginning balance at Dec. 31, 2024 $ 382,824 $ 29 1,727,610 291 (1,345,106)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock in connection with restricted stock units, net of tax (in shares)   408,000      
Issuance of common stock in connection with restricted stock units, net of tax 1 $ 1      
Stock-based compensation 6,024   6,024    
Other comprehensive loss (133)     (133)  
Net loss $ (52,195)       (52,195)
Ending balance (in shares) at Mar. 31, 2025 295,283,653 295,284,000      
Ending balance at Mar. 31, 2025 $ 336,521 $ 30 $ 1,733,634 $ 158 $ (1,397,301)